Skip to content

News

Organization Information

333 Lakeside Dr
Foster City CA 94404-1147
Phone: (650) 574-3000
Fax: (650) 522-5853

www.gilead.com

Ownership: Public
Stock Symbol: GILD
Revenue: $1.9 Billion

Our Leadership

  • John C. Martin, Ph.D., Chairman & CEO
  • John F. Milligan, Ph.D., Chief Operating Officer
  • Norbert W. Bischofberger, Ph.D., Executive VP, Research and Development and Chief Scientific Officer
  • Kevin Young, Executive VP, Commercial Operations
  • Gregg H. Alton, Executive Vice President, Corporate and Medical Affairs
  • William A. Lee, Ph.D., Senior VP, Research
  • Cristin Lis, Senior Director, Government Affairs
  • Kacy Hutchison, Senior Director, Government Affairs
  • Simone Wojtowicz, Assistant to John Martin
  • Louis Lange, M.D., Ph.D., Executive Vice President, Cardiovascular Therapeutics
  • Robin L. Washington, Senior Vice President and Chief Financial Officer
  • Maggie Levy, Executive Assistant to Robin Washington
  • Andrew Cheng, MD, PhD, SVP, Development Operations
  • Lauren Gollaher, Government Affairs Associate
Founded: 1987
Region: Bay Area , Los Angeles
CA Employees: 1820
Total Employees: 3400
Organization Type: Biotech

Gilead Sciences, Inc.

Organization Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Disease Focus

Cancer (misc) , Cardiovascular Disorder (misc) , Cytomegalovirus (CMV) , Hepatitis (misc) , Hepatitis-C , HIV/AIDS , Immune Disorder (non-specific) , Infection/Antibiotics , Infectious Disease (misc) , Influenza , Kaposi's Sarcoma , Kidney/Urinary Tract Disorder (misc) , Leukemia (acute pro-myelocytic)